Genetically engineered cardiac pacemaker: Stem cells transfected with HCN2 gene and myocytes - A model

被引:1
|
作者
Kanani, S. [1 ,2 ,5 ]
Pumir, A. [1 ,3 ,4 ,5 ]
Krinsky, V. [1 ,5 ]
机构
[1] CNRS, Inst Non Linear Nice, F-06560 Valbonne, France
[2] Inst Genom Fonct, F-34396 Montpellier, France
[3] Univ Nice, F-06108 Nice, France
[4] CNRS, Lab JA Dieudonne, F-06108 Nice, France
[5] Univ Nice, F-06560 Valbonne, France
关键词
biological pacemaker; gene therapy; oscillation; ion channels; stem cells;
D O I
10.1016/j.physleta.2007.07.075
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
One of the successfully tested methods to design genetically engineered cardiac pacemaker cells consists in transfecting a human mesenchymal stem cell (hMSC) with a HCN2 gene and connecting it to a myocyte. We develop and study a mathematical model, describing a myocyte connected to a hMSC transfected with a HCN2 gene. The cardiac action potential is described both with the simple Beeler-Reuter model, as well as with the elaborate dynamic Luo-Rudy model. The HCN2 channel is described by fitting electrophysiological records, in the spirit of Hodgkin-Huxley. The model shows that oscillations can occur in a pair myocyte-stem cell, that was not observed in the experiments yet. The model predicted that: (1) HCN pacemaker channels can induce oscillations only if the number of expressed IK1 channels is low enough. At too high an expression level of IK1 channels, oscillations cannot be induced, no matter how many pacemaker channels are expressed. (2) At low expression levels of IK1 channels, a large domain of values in the parameter space (n, N) exists, where oscillations should be observed. We denote N the number of expressed pacemaker channels in the stem cell, and n the number of gap junction channels coupling the stem cell and the myocyte. (3) The expression levels of IK1 channels observed in ventricular myocytes, both in the Beeler-Reuter and in the dynamic Luo-Rudy models are too high to allow to observe oscillations. With expression levels below similar to 4/4 of the original value, oscillations can be observed. The main consequence of this work is that in order to obtain oscillations in an experiment with a myocyte-stem cell pair, increasing the values of n, N is unlikely to be helpful, unless the expression level Of IK1 has been reduced enough. The model also allows us to explore levels of gene expression not yet achieved in experiments, and could be useful to plan new experiments, aimed at improving the robustness of the oscillations. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [31] Cardioprotective Effects Of Genetically Engineered Cardiac Stem Cells By Spheroid Formation On Ischemic Cardiomyocytes
    Jeong, Han Saem
    Kim, Jong-ho
    Hong, Soon Jun
    CIRCULATION RESEARCH, 2022, 131
  • [32] Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
    K Nakamura
    Y Ito
    Y Kawano
    K Kurozumi
    M Kobune
    H Tsuda
    A Bizen
    O Honmou
    Y Niitsu
    H Hamada
    Gene Therapy, 2004, 11 : 1155 - 1164
  • [33] Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
    Nakamura, K
    Ito, Y
    Kawano, Y
    Kurozumi, K
    Kobune, M
    Tsuda, H
    Bizen, A
    Honmou, O
    Niitsu, Y
    Hamada, H
    GENE THERAPY, 2004, 11 (14) : 1155 - 1164
  • [34] Suicide Gene Therapy of Glioma Using Genetically Engineered Human Mesenchymal Stem Cells
    Namba, Hiroki
    Li, Shaoyi
    Tokuyama, Tsutomu
    Yamamoto, Junkoh
    Yokota, Naoki
    MOLECULAR THERAPY, 2006, 13 : S139 - S139
  • [35] Genetically modified mesenchymal stem/stromal cells transfected with adiponectin gene can stably secrete adiponectin
    Hossain, Md. Murad
    Murali, Malliga Raman
    Kamarul, Tunku
    LIFE SCIENCES, 2017, 182 : 50 - 56
  • [36] Molecular and functional expression of ClC-2 channels in mammalian cardiac myocytes and pacemaker cells
    Britton, F
    Ye, LY
    Hatton, W
    Horowitz, B
    Hume, JR
    Duan, DY
    CIRCULATION, 2001, 104 (17) : 217 - 217
  • [37] Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area
    M Aoki
    R Morishita
    J Higaki
    A Moriguchi
    S Hayashi
    H Matsushita
    I Kida
    N Tomita
    Y Sawa
    Y Kaneda
    T Ogihara
    Gene Therapy, 1997, 4 : 120 - 127
  • [38] Novel approaches for gene-specific interference via manipulating actions of microRNAs: Examination on the pacemaker channel genes HCN2 and HCN4 (Retraction of 212, pg 285, 2007)
    Xiao, J.
    Yang, B.
    Lin, H.
    Lu, Y.
    Luo, X.
    Wang, Z.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (02) : 877 - 877
  • [39] Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model
    Tse, Hung-Fat
    Xue, Tian
    Lau, Chu-Pak
    Siu, Chung-Wah
    Wang, Kai
    Zhang, Qing-Yong
    Tomaselli, Gordon F.
    Akar, Fadi G.
    Li, Ronald A.
    CIRCULATION, 2006, 114 (10) : 1000 - 1011
  • [40] Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model
    Gu, Chunyu
    Li, Shaoyi
    Tokuyama, Tsutomu
    Yokota, Naoki
    Namba, Hiroki
    CANCER LETTERS, 2010, 291 (02) : 256 - 262